StockData
Polomar Health Services, Inc. logo

Polomar Health Services, Inc. (PMHS) stock

PMHSOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30
$0.12−0.01 (-4.00%)

Close on Oct 19, 2026Market cap $3.37MP/E –Yield –

Polomar Health Services operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Polomar Health Services's operating income for the twelve months ending Jun 30, 2026 was -$9.36M. For fiscal 2025 it was -$10.55M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$10.55M–
FY2024Dec 31, 2024-$1.30M–
FY2023Dec 31, 2023-$440.83K–
FY2022Dec 31, 2022-$181.45K–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$218.38K–
Q1 FY2026Mar 31, 2026-$6.90K–
Q4 FY2025Dec 31, 2025-$8.94M–
Q3 FY2025Sep 30, 2025-$628.81K–
Q2 FY2025Jun 30, 2025-$563.33K–
Q1 FY2025Mar 31, 2025-$415.41K–
Q4 FY2024Dec 31, 2024-$689.11K–
Q3 FY2024Sep 30, 2024-$259.17K–
Q2 FY2024Jun 30, 2024-$190.74K–
Q1 FY2024Mar 31, 2024-$160.47K–
Q4 FY2023Dec 31, 2023-$94.54K–
Q3 FY2023Sep 30, 2023-$134.68K–
Q2 FY2023Jun 30, 2023-$90.96K–
Q1 FY2023Mar 31, 2023-$89.81K–
Q4 FY2022Dec 31, 2022-$151.98K–
Q3 FY2022Sep 30, 2022-$13.52K–
Q2 FY2022Jun 30, 2022-$13.71K–

More Polomar Health Services figures

See a number that looks wrong?